✦ LIBER ✦

Phase II trial of sequential gefitinib after minor response or partial response to chemotherapy in Chinese patients with advanced non-small-cell lung cancer

✍ Scribed by Jian Ming Xu; Yu Han; Yue Min Li; Chuan Hua Zhao; Yan Wang; Angelo Paradiso

Book ID: 115010915
Publisher: BioMed Central
Year: 2006
Tongue: English
Weight: 261 KB
Volume: 6
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-6-288

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of gefitinib in pretreate

Phase II trial of gefitinib in pretreated Chinese women with advanced non-small-cell lung cancer

✍ Jing Deng, Wei Jia Fang, Xiao Chen Zhang, Dong Ping Wu, Hong Ming Fang, Jing Che 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 178 KB

Lack of response to erlotinib after prog

Lack of response to erlotinib after progression on gefitinib in patients with advanced non-small cell lung cancer

✍ Viswanathan, Avinash; Pillot, Giancarlo; Govindan, Ramaswamy 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 72 KB

A phase II trial of gefitinib as mainten

A phase II trial of gefitinib as maintenance therapy after first-line chemotherapy for advanced non-small cell lung cancer in China

✍ Lu Yang; Zhi-jie Wang; Tong-tong An; Hua Bai; Jun Zhao; Jian-chun Duan; Ping-pin 📂 Article 📅 2010 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 283 KB

Prospective Study of Gefitinib Readminis

Prospective Study of Gefitinib Readministration After Chemotherapy in Patients With Advanced Non–Small-Cell Lung Cancer Who Previously Responded to Gefitinib

✍ Tomonobu Koizumi; Toshihiko Agatsuma; Kayoko Ikegami; Toshiro Suzuki; Takashi Ko 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 322 KB

Phase II trial of sequential gemcitabine

Phase II trial of sequential gemcitabine followed by cisplatin in patients with advanced non small cell lung cancer

✍ Foo, K.F; Leong, S.S; Ang, P; See, H.T; Ong, S; Wee, J; Fong, K.W; Machin, D; Ta 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Randomized phase II study of gefitinib v

Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy

✍ Kim, Seung Tae; Uhm, Ji Eun; Lee, Jeeyun; Sun, Jong-mu; Sohn, Insuk; Kim, Seon W 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 359 KB